Table 3 3D Gamma analysis results for male cohort (n = 20) and female cohort (n = 20) (mean ± 1 SD)
From: Validation of an MRI-only planning workflow for definitive pelvic radiotherapy
3%/2 mm | 2%/2 mm | 1%/1 mm | ||||
|---|---|---|---|---|---|---|
Pass rate (%) | Av Gamma | Pass rate (%) | Av Gamma | Pass rate (%) | Av Gamma | |
Male cohort | 99.8 \(\pm\) 0.2 | 0.10 \(\pm\) 0.03 | 99.7 \(\pm\) 0.3 | 0.15 \(\pm\) 0.04 | 96.3 \(\pm\) 3.1 | 0.31 \(\pm\) 0.09 |
Range | 100.0–99.3 | 0.07–0.18 | 100.0–99.0 | 0.11–0.25 | 99.2–88.7 | 0.21–0.52 |
Female cohort | 99.8 \(\pm\) 0.3 | 0.13 \(\pm\) 0.04 | 99.7 \(\pm\) 0.4 | 0.19 \(\pm\) 0.05 | 93.4 \(\pm\) 5.2 | 0.38 \(\pm\) 0.12 |
Range | 100.0–99.1 | 0.08–0.19 | 100.0–98.8 | 0.11–0.28 | 99.1–81.0 | 0.23–0.57 |